Home›Companies›Biotech & Pharma›Anodyne Nanotech

Anodyne Nanotech, Inc.

Develops skin patches to deliver medicines for people with chronic diseases.

Updated Nov 13, 2026·Latest SEC filing Jun 11, 2026·Suggest an edit

About Anodyne Nanotech

Anodyne Nanotech is a private company based in Boston, Massachusetts. It has reported $16,023,755 raised in three offerings on Form D since August 2020.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 27, 2026Jun 11, 2026$12,597,058of $17.2M target47$268KEquity, OptionsRule 506(b)Form D ↗
Feb 19, 2021Feb 25, 2021amended May 7, 2021$1,957,280fully sold15$130KDebtRule 506(b)Form D/A ↗1 earlier filing
Jul 24, 2020Aug 7, 2020$1,469,417of $2.3M target20$73,471EquityRule 506(b)Form D ↗
Total, three offerings$16,023,755

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Anodyne Nanotech's Form D filed Jun 11, 2026.

MS
Michael Singer
Senior Advisor and director
VL
Vikram Lamba
Director
KT
Konstantinos Tzortzakis
Co-Founder & CBO, director
LJ
Lombardo Jake
Executive officer and director

Earlier filings also listed Lampros Kourtis (director, last listed May 2021), Hojatollah Rezaei Nejad (executive officer, last listed May 2021) and Achilleas Gravanis (director, last listed May 2021).

Sources

  1. SECAnodyne Nanotech, Inc. Form D, filed Feb 25, 2021
  2. SECAnodyne Nanotech, Inc. filing history
  3. CompanyAnodyne Nanotech about